These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18380349)

  • 21. [Role of pre-mRNA secondary structures in the regulation of alternative splicing].
    Rubtsov PM
    Mol Biol (Mosk); 2016; 50(6):935-943. PubMed ID: 28064309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterochromatin dysregulation in human diseases.
    Hahn M; Dambacher S; Schotta G
    J Appl Physiol (1985); 2010 Jul; 109(1):232-42. PubMed ID: 20360431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation.
    Lopez AJ
    Annu Rev Genet; 1998; 32():279-305. PubMed ID: 9928482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanisms and functions underlying neuronal activity-dependent alternative pre-mRNA splicing].
    Iijima T
    Seikagaku; 2013 Jul; 85(7):570-4. PubMed ID: 23980473
    [No Abstract]   [Full Text] [Related]  

  • 26. [Genetic diagnosis of the hypotonic newborn].
    Bauer MS
    Rev Neurol; 1997 May; 25(141):703-6. PubMed ID: 9206594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Guiding and integrating to control and diversify splicing].
    Fisette JF; Michelle L; Revil T; Chabot B
    Med Sci (Paris); 2009 Feb; 25(2):175-80. PubMed ID: 19239850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA processing and human disease.
    Philips AV; Cooper TA
    Cell Mol Life Sci; 2000 Feb; 57(2):235-49. PubMed ID: 10766020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I.
    Leroy O; Dhaenens CM; Schraen-Maschke S; Belarbi K; Delacourte A; Andreadis A; Sablonnière B; Buée L; Sergeant N; Caillet-Boudin ML
    J Neurosci Res; 2006 Sep; 84(4):852-9. PubMed ID: 16862542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.
    Dhaenens CM; Tran H; Frandemiche ML; Carpentier C; Schraen-Maschke S; Sistiaga A; Goicoechea M; Eddarkaoui S; Van Brussels E; Obriot H; Labudeck A; Gevaert MH; Fernandez-Gomez F; Charlet-Berguerand N; Deramecourt V; Maurage CA; Buée L; Lopez de Munain A; Sablonnière B; Caillet-Boudin ML; Sergeant N
    Biochim Biophys Acta; 2011 Jul; 1812(7):732-42. PubMed ID: 21439371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myotonic dystrophy: RNA-mediated muscle disease.
    Wheeler TM; Thornton CA
    Curr Opin Neurol; 2007 Oct; 20(5):572-6. PubMed ID: 17885447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of mammalian pre-mRNA splicing.
    Hui J
    Sci China C Life Sci; 2009 Mar; 52(3):253-60. PubMed ID: 19294350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative splicing in stem cell self-renewal and diferentiation.
    Nelles DA; Yeo GW
    Adv Exp Med Biol; 2010; 695():92-104. PubMed ID: 21222201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
    Revil T; Shkreta L; Chabot B
    Bull Cancer; 2006 Sep; 93(9):909-19. PubMed ID: 16980234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signals, pathways and splicing regulation.
    Blaustein M; Pelisch F; Srebrow A
    Int J Biochem Cell Biol; 2007; 39(11):2031-48. PubMed ID: 17507279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs.
    Yuan Y; Compton SA; Sobczak K; Stenberg MG; Thornton CA; Griffith JD; Swanson MS
    Nucleic Acids Res; 2007; 35(16):5474-86. PubMed ID: 17702765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative splicing of mutually exclusive exons--a review.
    Pohl M; Bortfeldt RH; Grützmann K; Schuster S
    Biosystems; 2013 Oct; 114(1):31-8. PubMed ID: 23850531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural investigations of the RNA-binding properties of STAR proteins.
    Feracci M; Foot J; Dominguez C
    Biochem Soc Trans; 2014 Aug; 42(4):1141-6. PubMed ID: 25110016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-mRNA splicing and human disease.
    Faustino NA; Cooper TA
    Genes Dev; 2003 Feb; 17(4):419-37. PubMed ID: 12600935
    [No Abstract]   [Full Text] [Related]  

  • 40. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.
    Ho TH; Bundman D; Armstrong DL; Cooper TA
    Hum Mol Genet; 2005 Jun; 14(11):1539-47. PubMed ID: 15843400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.